BPC
FATE icon

Banque Pictet & Cie’s Fate Therapeutics FATE Stock Holding History

Banque Pictet & Cie’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-44,394
Closed -$995K – 623
2022
Q3 		$995K Sell
44,394
-166
-0.4% -$4.8K 0.01% 397
2022
Q2 		$1.1M Sell
44,560
-4,295
-9% -$119K 0.01% 413
2022
Q1 		$1.89M Buy
48,855
+1,893
+4% +$73.3K 0.01% 345
2021
Q4 		$2.75M Buy
+46,962
New +$2.66M 0.02% 285

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Banque Pictet & Cie's FATE Position: Q4 2022 in Review

Banque Pictet & Cie sold out of Fate Therapeutics (FATE) in Q4 2022, closing a stake of 44,394 shares — an estimated $995K sold.

Banque Pictet & Cie first reported a position in FATE in Q4 2021 and held it in 4 quarters. The position peaked at $2.75M in Q4 2021. 227 funds tracked by Wall St. Rank hold FATE as of Q4 2022.

  • Banque Pictet & Cie reported no remaining Fate Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Banque Pictet & Cie sold 44,394 Fate Therapeutics shares in Q4 2022, an estimated $995K.
  • Banque Pictet & Cie first reported a position in Fate Therapeutics in Q4 2021 and held it in 4 quarters.
  • Banque Pictet & Cie's Fate Therapeutics position peaked at $2.75M in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2022.

Based on Banque Pictet & Cie's 13F filing for Q4 2022, filed 6 Feb 2023.